Backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS), Lumexa Imaging sold 25 million shares at $18.50 apiece, compared with the marketed range of $17 to $20 per share. The IPO valued ...
Figure Technology Solutions, Inc. ( FIGR) Goldman Sachs 2025 U.S. Financial Services Conference December 10, 2025 12:20 PM ...
Shareholders of this FTSE 100 investment trust may have just got an early Christmas present from Space Exploration ...
SpaceX IPO 2026 is shaping up to be the biggest in history, targeting a $1.5 trillion valuation and a record $30 billion raise. SpaceX now controls 65% of all satellites, with 7,600 in orbit and 8.5 ...
Discover how IPO Genie is offering fans a chance to win a VIP trip to Dubai for Tate vs DeMoor. Enter the official giveaway ...
Sarah Friar tells WSJ Tech & Media Editor Sarah Krouse that the AI firm isn’t ready to discuss an IPO and is still in growth mode. Photo: Nikki Ritcher for WSJ OpenAI Chief Financial Officer Sarah ...
Navan, the corporate travel and expense platform, finished its first day of trading on the Nasdaq on Thursday down 20% from its $25 IPO price, resulting in a valuation of approximately $4.7 billion ...
Welcome back to The Prompt, ChatGPT maker OpenAI is setting its eyes on an IPO as soon as late 2026, according to a Reuters report. The IPO could double the AI behemoth’s valuation to $1 trillion and ...
Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 to $17 per share. The California biotech announced its IPO intentions ...
OpenAI hasn’t formally committed to an IPO, but CEO Sam Altman, in a livestream broadcast discussing the new structure, said an initial public offering was the most likely path for the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback